Leucopenia in the First Year After Renal Transplantation During Valganciclovir Prophylaxis.

被引：0
|
作者：
Rissling, O. [1 ]
Naik, M. [1 ]
Brakemeier, S. [1 ]
Schmidt, D. [1 ]
Hohberger, A. [1 ]
Neumayer, H. [1 ]
Budde, K. [1 ]
机构：
[1] Charite CCM, Dept Nephrol, Berlin, Germany
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-02657
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
D2414
引用
收藏
页码：777 / 777
页数：1
相关论文
共 50 条
  • [1] Leucopenia in the First Year After Renal Transplantation During Valganciclovir Prophylaxis
    Rissling, O.
    Naik, M.
    Brakemeier, S.
    Schmidt, D.
    Hohberger, A.
    Neumayer, H.
    Budde, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 777 - 777
  • [2] Valganciclovir Prophylaxis is Not Associated with Polyomavirus Viremia after Renal Transplantation
    Conti, D.
    Schuster, D.
    Garner, M.
    Maciera, E.
    Patel, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 821 - 821
  • [3] Bone mineral density after renal transplantation: Implications for prophylaxis.
    O'Shaughnessy, EA
    Dahl, DC
    Kasiske, BL
    Smith, CL
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S487 - S487
  • [4] 24 Weeks of Valganciclovir Prophylaxis in Children After Renal Transplantation: A 4-Year Experience
    Camacho-Gonzalez, Andres F.
    Gutman, Julie
    Hymes, Leonard C.
    Leong, Traci
    Hilinski, Joseph A.
    [J]. TRANSPLANTATION, 2011, 91 (02) : 245 - 250
  • [5] 24 Weeks of Valganciclovir Prophylaxis in Children after Renal Transplantation: A Four Year Experience.
    Camacho-Gonzalez, Andres F.
    Hymes, Leonard C.
    Gutman, Julie
    Hilinski, Joseph A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 344 - 344
  • [6] Low Dose Valganciclovir for CMV Prophylaxis in the First Year of Kidney Transplantation
    Klem, P.
    Al-Omar, L.
    Cooper, J.
    Davis, S.
    Gralla, J.
    Choe, D.
    Wiseman, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 468 - 468
  • [7] Varicella Zoster Infection Under Valganciclovir Prophylaxis After Renal Transplantation
    Bardak, Simge
    Turgutalp, Kenan
    Koyuncu, Mahmut Bakir
    Ersoz, Gulden
    Kiykim, Ahmet
    [J]. TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2016, 25 (01): : 104 - 106
  • [8] High frequency of valganciclovir underdosing for cytomegalovirus prophylaxis after renal transplantation
    Rissling, Olesja
    Naik, Marcel
    Brakemeier, Susanne
    Schmidt, Danilo
    Staeck, Oliver
    Hohberger, Arnim
    Neumayer, Hans-Hellmut
    Budde, Klemens
    [J]. CLINICAL KIDNEY JOURNAL, 2018, 11 (04) : 564 - 573
  • [9] CMV VALGANCICLOVIR PROPHYLAXIS VERSUS PREEMPTIVE THERAPY AFTER RENAL TRANSPLANTATION: TWO YEAR RESULTS OF A RANDOMIZED CLINICAL TRIAL
    Witzke, O.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 31 - 32
  • [10] CMV VALGANCICLOVIR PROPHYLAXIS VERSUS PREEMPTIVE THERAPY AFTER RENAL TRANSPLANTATION: ONE YEAR RESULTS OF A RANDOMIZED CLINICAL TRIAL
    Witzke, O.
    Nitschke, M.
    Bartels, M.
    Ott, U.
    Hauser, I. A.
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 12 - 12
12345